A new international Phase 3 clinical trial coordinated by Crick Senior Group Leader and Cancer Research UK's chief clinician, Charles Swanton, will use personalised detection tests to look for the earliest signs of relapse ...
May 26, 2020
0
1
Scientists at St. Jude Children's Research Hospital and Princess Margaret Cancer Centre in Toronto, Canada, have reported that subpopulations of leukemic cells present at diagnosis can cause relapse in children with acute ...
Mar 3, 2020
0
9
A study at The University of Texas MD Anderson Cancer Center showed that circulating tumor cells (CTCs), a form of liquid biopsy, was independently associated with melanoma relapse, suggesting CTC assessment may be useful ...
Feb 3, 2020
0
4
Despite modern therapies, 10% of patients with acute lymphoblastic leukemia (ALL) treated in the U.S. relapse, which dramatically reduces their chance of survival. Results from a St. Jude Children's Research Hospital clinical ...
Oct 28, 2019
0
2
Doctoral research by Annemieke Witteveen at the University of Twente has shown that the number of follow-up visits for women after breast cancer treatment in the Netherlands could be reduced by about 9,000 visits per year. ...
Nov 8, 2018
0
0
Resistance to therapy is a major problem in cancer patients, as resistant cells are at the root of tumour relapse and are associated with high morbidity and mortality. A better understanding of the mechanisms associated with ...
Oct 10, 2018
0
22
(HealthDay)—The U.S. Food and Drug Administration is warning patients with cancers of the blood or lymph nodes who undergo a donor stem cell transplant not to take azithromycin, as long-term use of the antibiotic has been ...
Aug 13, 2018
0
2
Cancer cells in children tend to develop by following four main trajectories—and two of them are linked to relapse of the disease, according to a study led by Lund University in Sweden, now published in Nature Genetics. ...
Jun 5, 2018
0
5
Researchers at Okayama University report in Oncotarget a promising method for targeting cancer stem cells that cause tumor growth and cancer relapse. The approach involves administering molecules that capture iron, an overload ...
Feb 27, 2018
1
11
It is possible to have breaks in long-term medication against hormone-sensitive breast cancer without influencing the effect of the treatment. Women also feel better if they take a three-month break from the hormone treatment ...
Dec 1, 2017
0
2
